Related Experiment Videos
[Sarcoidosis following pegylated interferon therapy: two cases]
Souad Benali1, Christian Boustière, Paul Castellani
1Service d'Hépato-Gastroentérologie, Hôpital Saint Joseph, Marseille.
Abstract:
One side effect of the immunomodulatory effect of interferon is the possible triggering or exacerbation of systemic or cutaneous sarcoidosis. We report two new cases and offer an exhaustive review of the literature. A 39-year-old man with type C chronic active hepatitis developed new respiratory symptoms and pulmonary infiltrates with hilar and mediastinal adenopathy after 7 months of treatment with pegylated interferon. The evolution was favourable after stopping treatment. The second patient developed cutaneous lesions after 6 months of treatment. Resolution occurred after the discontinuation of the treatment. In these two cases ribavirin was stopped before the first signs of sarcoidosis.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Rocky Mountain Spotted Fever
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...